Shu-Wei Liang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
There is an urgent clinical need for targeted therapy approaches for triple-negative breast cancer (TNBC) patients. Increasing evidences suggested that the expression of estrogen-related receptor alpha (ERRα) was correlate with unfavorable clinical outcomes of breast cancer patients. We here show that inhibition of ERRα by its inverse agonist XCT-790 can(More)
  • 1